Treatment of Severe Pulmonary Hypertension Secondary to Connective Tissue Diseases With Continuous IV Epoprostenol (Prostacyclin)
- 1 July 1998
- Vol. 114 (1) , 80S-82S
- https://doi.org/10.1378/chest.114.1_supplement.80s
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)Annals of Internal Medicine, 1990
- Pulmonary hypertension in the crest syndrome variant of systemic sclerosisArthritis & Rheumatism, 1986
- Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 1984
- LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)The Lancet, 1984
- Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosisThe American Journal of Medicine, 1983
- Pulmonary Hypertension in the CREST Syndrome Variant of Progressive Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1977